Guided Therapeutics

Guided Therapeutics received a $700,000 purchase order from Hangzhou Dongye Medical Technology Company Ltd for 35 LuViva Advanced Cervical Scan systems, with deliveries starting in July 2025.

Guided Therapeutics received full payment for an order from Indonesia for four LuViva Advanced Cervical Scan devices and 1,200 single-use cervical guides, to be delivered in Q1 2025.

Guided Therapeutics received a $2,538,070 purchase order from its Chinese partner Shandong Yaohuo Medical Device Technology Company for parts and disposables for the LuViva cervical cancer detection device. The order is contingent on Chinese FDA approval expected within about one year.

Guided Therapeutics received a $2,538,070 purchase order from its Chinese partner Shandong Yaohuo Medical Device Technology Company for parts and disposables for the LuViva cervical cancer testing device.

Guided Therapeutics signed a multiyear license agreement with Turkish distribution partner ITEM for the manufacture of patented single-patient-use Cervical Guides in Turkey. The agreement includes fees totaling $1.1 million in 2018 and expected minimum revenues of approximately $19.4 million over twelve years.